期刊文献+

86例复发性尿路感染的临床治疗分析 被引量:12

Clinical treatment of 86 patients with recurrent urinary tract infections
原文传递
导出
摘要 目的观察规则抗菌疗法治疗复发性尿路感染的临床疗效及安全性。方法选取医院2010年2月-2011年1月收治的复发性尿路感染患者作为研究资料,根据病情分为难治组及对照组,给予规则分期抗菌治疗方法,观察尿常规、尿培养情况。结果共86例患者,治愈75例,治愈率为87.21%,有效7例,有效率为8.14%,其中有2例患糖尿病,3例有肾结石,1例为肾移植术后,均为病情的维持期,无效4例,无效率为4.65%,其中2例为肾结石伴肾功能不全,2例为肾移植术后;治愈的75例患者治疗疗程为24~120周,平均(52.3±22.4)周,治疗期为6~76周,平均(21.3±16.3)周,巩固期为5~14周,平均(6.13±2.41)周,55例按计划完成治疗,31例不同程度过渡到巩固期。结论采用规则抗菌疗法治疗复发性尿路感染疗效可靠,治愈率高,且未见肝肾功能等不良反应。 OBJECTIVE To observe the clinical efficacy and safety of the rules of antimicrobial therapy for recurrent urinary tract infections.METHODS The patients with recurrent urinary tract infections who enrolled in hospital from Feb 2010 to Jan 2011 were selected as study subjects and were divided into the refractory group and the control group according to the condition of the diseases,the regular phases of antimicrobial therapy was performed,the results of the urinalysis and the urine culture were observed.RESULTS Of 86 cases of patients investigated,75 cases were cured with the cure rate of 87.21% 7 cases were effective with the effective rate of 8.14%,among which there were 2 cases with diabetes,3 cases with kidney stones,and 1 case of renal transplantation,all these patients were at maintenance stage of the disease;4 cases were ineffective with the ineffective rate of 4.65%,including 2 cases of kidney stones with renal insufficiency and 2 cases of renal transplantation;the course of treatment of the 75 cured patients was 24-120 weeks,with the mean of(52.3±22.4) weeks,the treatment period was 6-76 weeks,with the mean of(21.3±16.3) weeks,and consolidation period was 5-14 weeks,with the mean of(6.13±2.41) weeks;55 cases completed the scheduled treatment,31 patients with different degree of diseases transferred to consolidation period.CONCLUSION The clinical efficacy of rules of antimicrobial therapy for recurrent urinary tract infections is reliable with high cure rate and without any adverse reactions.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第8期1610-1611,共2页 Chinese Journal of Nosocomiology
关键词 规则抗菌疗法 尿路感染 疗效观察 Rules of antimicrobial therapy Urinary tract infection Observation of efficacy
  • 相关文献

参考文献9

  • 1Robert A,Ahmed R. Si milarities and differences in CD4 +and CD8+ effector and memory Tcell generation[J].Nature I mmunology,2003,(09):563-581.
  • 2Karaca Y,Coplu N,Gozalan A. Cotrimoxazole and quinoloneresistance in Escherichia coli isolated from urinary tract infections overthe last 10 years[J].Int J Antim icrob Agents,2005,(01):75-77.
  • 3Ibbotson SH,Jong C,Lesar A. Characteristics of 5-aminolaevulinic acid-induced protoporphyrin Ⅸ fluorescence in human skin in vivo[J].Photodermatology Photoimmunology and Photomedicine,2006,(02):105-110.
  • 4RM O'Connell,KD Taganov,MP Boldin. MicroRNA155 is induced during the macrophage inflammatory response[J].Proceedings of the National Academy of Sciences(USA),2007.1604-1609.
  • 5Dwyer PL,O' Reilly M. Recurrent urinary tract infection in the female[J].Current Opinion in Obstetrics and Gynecology,2002,(05):537-543.
  • 6Choudry K,Brooke RC,Farrar W. Yhe effect of an iron chelating agent on protoporphyrin Ⅸ levels and phototoxicity in topical 5-aminolaevulinic acidphotodynamic therapy[J].British Journal of Dermatology,2003,(01):124.doi:10.1046/j.1365-2133.2003.05351.x.
  • 7Taganov KD,Boklin MP,Chang KJ. NF-KappaB-dependent induction of microRNAmi R-146,aninhiblor targetedto signaling proteins of innate immune responses[J].Proceedings of the National Academy of Sciences(USA),2006,(33):12481-12486.
  • 8Akira S,Takeda K. Toll-like receptor signaling[J].Nature Reviews Immunology,2004,(07):499-511.
  • 9Uehling DT,Hopkins WJ,Elkahwaji JE. Phase 2 clinicaltrial of a vaginal mucosal vaccine for urinary tract infections[J].The Journal of Urology,2003,(03):867-868.

同被引文献95

  • 1付志荣,蔡玲.谈患者用药依从性与临床疗效的关系[J].时珍国医国药,2005,16(10):1056-1057. 被引量:26
  • 2Bazian,唐艳(译),马俊(译),许良智(审校).预防非妊娠期妇女复发性膀胱炎的临床证据[J].中国循证医学杂志,2006,6(1):55-57. 被引量:2
  • 3戴奇山,何朝晖,何永忠,戚德峰,李逊,钟惟德.经皮肾微造瘘治疗肾切开取石术后复发肾结石[J].中国内镜杂志,2006,12(3):300-300. 被引量:5
  • 4张承英,张建荣,耿艳秋,丁韬.胸腺五肽联合抗生素治疗复发性尿路感染疗效分析[J].武警医学,2007,18(4):272-275. 被引量:4
  • 5Boylu U, Oommen M, Raynor M, et al. Ureteroenteric anastomotic stricture:novel use of a cutting balloon dilator. J Endourol, 2010,24(7):1175-1178.
  • 6Parente HemAndez A, Angulo Madero JM, Romero Ruiz RM,et al. Medium-term results of the endourological management with balloon dilatation of the ureteropelvic junction stenesis in infants. Actas Urol Esp, 2009,33 ( 4 ) : 422-428.
  • 7Sakhaee K, Maalouf NM, Sinnott B,et al. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab, 2012,97(6): 1847-1860.
  • 8Cracco CM, Scoffone CM, Scarpa RM. New developments in percutaneous techniques for simple and complex branched renal stones. Curr Opin Urol, 2011,21 (2) : 154-160.
  • 9Nosseir SB, Lind LR, Winlder HA. Recurrent Uncomplicated Urinary Tract Infections in Women:A review[J]. Journal of women's health, 2012,21 (3) :347 - 352.
  • 10Carraro-Eduardo JC, Gava IA. Use of vaccines for prophylaxis of uri- nary tract infections [ J]. Jornal brasileiro de nefrologia, 2012, 34(2) :178 - 183.

引证文献12

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部